RCKT - Rocket falls as FDA rejects gene therapy Kresladi
2024-06-28 08:21:35 ET
More on Rocket Pharmaceuticals
- Rocket Pharmaceuticals: Cautiously Optimistic (Rating Upgrade)
- Rocket Pharmaceuticals: Multiple Regulatory Submissions Make It A Must Watch
- Cantor picks 14 undervalued biotech stocks worth a second look
- Rocket Pharma gains as EU accepts gene therapy for review
- Seeking Alpha’s Quant Rating on Rocket Pharmaceuticals